ALICIA
MENDILUCE HERRERO
PROFESOR ASOCIADO CIENCIAS DE LA SALUD
Fundación Jiménez Díaz
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Fundación Jiménez Díaz (3)
2022
-
Bioavailability of once-daily tacrolimus formulations used in clinical practice in the management of De Novo kidney transplant recipients: the better study
Clinical transplantation, Vol. 36, Núm. 3, pp. e14550
2009
-
A randomized trial of basiliximab with three different patterns of cyclosporin A initiation in renal transplant from expanded criteria donors and at high risk of delayed graft function
Clinical Transplantation, Vol. 23, Núm. 1, pp. 23-32
1988
-
Role of platelet activating factor (PAF) antagonists in a rat model of cyclosporine nephrotoxicity
Nefrologia, Vol. 8, Núm. SUPPL. 1, pp. 30-37